A Randomised Assessment Of The Sequential Addition Of The Kinase Inhibitor Quizartinib To Intensive Chemotherapy In Older Acute Myeloid Leukaemia (Aml) Patients: Results From The Ncri Aml18 Trial
Quizartinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Randomised Assessment Of The Sequential Addition Of The Kinase Inhibitor Quizartinib To Intensive Chemotherapy In Older Acute Myeloid Leukaemia (Aml) Patients: Results From The Ncri Aml18 Trial ### Output: Quizartinib